EMRIS Pharma

Israel
Nazareth, Northern District, Israel

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$422,000
Last funding
Pre Seed / $422,000 / 2023-05-01
Last equity funding
Pre Seed / $422,000
Investors
2

Founders and investors

Investors

Israel Innovation AuthorityNGT Healthcare II